Point-of-Care Testing

Examining how emerging immunotherapies, multi-omics data integration, and lab-ready processes are reshaping translational research

The VELO system is an ultrafast point-of-care molecular diagnostics platform designed to deliver highly sensitive PCR results for key respiratory pathogens directly from a swab sample in under 10 minutes

Advances in point-of-care testing are shifting hemolysis detection from the bench to the bedside

The OSOM® RSV Test is a rapid immunochromatographic assay for the qualitative detection of RSV nucleoprotein antigen in anterior nasal swab specimens

Explore studies, workflows, and strategies that use rapid, point-of-care tools to overcome barriers to testing and treatment access for syphilis, HIV, and HCV

As clinical trial sponsors aim to reduce patient burden and improve engagement, point-of-care testing offers practical advantages

The test could enable at-home testing and increased access to testing for patients undergoing telehealth care or living in remote areas

Transform care in high-incidence settings with a 10-minute test that delivers same-visit treatment and better outcomes

With syphilis cases on the rise, NOWDx’s over-the-counter test offers rapid, in-home results in minutes and is now available nationwide in thousands of pharmacies and drugstore locations

A guide to effective utilization of NGS for liquid and tissue biopsies

The new malaria test can detect malaria without taking a single drop of blood

Lyophilized product advantages come from a specialized upfront development process

UCLA researchers look to create point-of-care test that can confirm diagnosis at the bedside

IntelliSep is the first and only FDA-cleared cellular host diagnostic indicated for use in the ED

Labcorp to serve as the exclusive NOWDiagnostics (NOWDx) distributor for clinical testing in the US, offering First to Know® Syphilis Test nationwide

To capture new demand, clinical labs should note advancing technology and rising disease mortality

First-time attendee explores new technologies and future solutions at the Association for Diagnostics in Laboratory Medicine Annual Lab Expo

Researchers studied whether two biomarkers could predict recurrence in head and neck cancer

First home antibody test can inform patients of current or past infection and lead to confirmatory testing with healthcare provider

Medway NHS Foundation Trust to transform local gestational diabetes screening by improving access to a new at-home diabetes testing technology